Abstract

Carbon-negative synthesis of biochemical products has the potential to mitigate global CO2 emissions. An attractive route to do this is the reverse β-oxidation (r-BOX) pathway coupled to the Wood-Ljungdahl pathway. Here, we optimize and implement r-BOX for the synthesis of C4-C6 acids and alcohols. With a high-throughput in vitro prototyping workflow, we screen 762 unique pathway combinations using cell-free extracts tailored for r-BOX to identify enzyme sets for enhanced product selectivity. Implementation of these pathways into Escherichia coli generates designer strains for the selective production of butanoic acid (4.9 ± 0.1 gL−1), as well as hexanoic acid (3.06 ± 0.03 gL−1) and 1-hexanol (1.0 ± 0.1 gL−1) at the best performance reported to date in this bacterium. We also generate Clostridium autoethanogenum strains able to produce 1-hexanol from syngas, achieving a titer of 0.26 gL−1 in a 1.5 L continuous fermentation. Our strategy enables optimization of r-BOX derived products for biomanufacturing and industrial biotechnology.

An attractive route for carbon-negative synthesis of biochemical products is the reverse β-oxidation pathway coupled to the Wood-Ljungdahl pathway. Here the authors use a high-throughput in vitro prototyping workflow to screen 762 unique pathway combinations using cell-free extracts tailored for r-BOX to identify enzyme sets for enhanced product selectivity.

Details

Title
Cell-free prototyping enables implementation of optimized reverse β-oxidation pathways in heterotrophic and autotrophic bacteria
Author
Vögeli, Bastian 1   VIAFID ORCID Logo  ; Schulz, Luca 1   VIAFID ORCID Logo  ; Garg, Shivani 2 ; Tarasava, Katia 3 ; Clomburg, James M. 4 ; Lee, Seung Hwan 3   VIAFID ORCID Logo  ; Gonnot, Aislinn 5 ; Moully, Elamar Hakim 6 ; Kimmel, Blaise R. 1   VIAFID ORCID Logo  ; Tran, Loan 2 ; Zeleznik, Hunter 2 ; Brown, Steven D. 2 ; Simpson, Sean D. 2 ; Mrksich, Milan 7   VIAFID ORCID Logo  ; Karim, Ashty S. 1   VIAFID ORCID Logo  ; Gonzalez, Ramon 3   VIAFID ORCID Logo  ; Köpke, Michael 5   VIAFID ORCID Logo  ; Jewett, Michael C. 1   VIAFID ORCID Logo 

 Northwestern University, Department of Chemical and Biological Engineering and Center for Synthetic Biology, Evanston, USA (GRID:grid.16753.36) (ISNI:0000 0001 2299 3507) 
 LanzaTech Inc., Skokie, USA (GRID:grid.16753.36) 
 University of South Florida, Department of Chemical, Biological, and Materials Engineering, Tampa, USA (GRID:grid.170693.a) (ISNI:0000 0001 2353 285X) 
 LanzaTech Inc., Skokie, USA (GRID:grid.170693.a); University of South Florida, Department of Chemical, Biological, and Materials Engineering, Tampa, USA (GRID:grid.170693.a) (ISNI:0000 0001 2353 285X) 
 LanzaTech Inc., Skokie, USA (GRID:grid.170693.a) 
 Northwestern University, Department of Biomedical Engineering, Evanston, USA (GRID:grid.16753.36) (ISNI:0000 0001 2299 3507); Northwestern University, Department of Chemistry, Evanston, USA (GRID:grid.16753.36) (ISNI:0000 0001 2299 3507) 
 Northwestern University, Department of Chemical and Biological Engineering and Center for Synthetic Biology, Evanston, USA (GRID:grid.16753.36) (ISNI:0000 0001 2299 3507); Northwestern University, Department of Biomedical Engineering, Evanston, USA (GRID:grid.16753.36) (ISNI:0000 0001 2299 3507); Northwestern University, Department of Chemistry, Evanston, USA (GRID:grid.16753.36) (ISNI:0000 0001 2299 3507) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2672171665
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.